Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 First Amendment to Notice of Articles of Angiotech Pharmaceuticals, Inc.
- 3.2 Second Amendment to Notice of Articles of Angiotech Pharmaceuticals, Inc.
- 3.3 Articles of Angiotech Pharmaceuticals, Inc.
- 4.1 Indenture
- 4.2 Supplemental Indenture
- 10.1 Credit Agreement
- 10.2 Registration Rights Agreement
- 10.3 Angiotech Pharmaceuticals, Inc. 2011 Stock Incentive Plan
- 10.4 Form of Restricted Share Unit Award Agreement (for Canadian Participants)
- 10.5 Form of Restricted Stock Award Agreement (for U.S. Participants)
- 10.6 Form of Stock Option/sar Award Agreement (for Canadian Participants)
- 10.7 Form of Stock Option/sar Award Agreement (for U.S. Participants)
- 99.1 Angiotech Pharmaceuticals Announces Final Implementation of
ANP similar filings
- 9 Aug 11 Angiotech Pharmaceuticals, Inc. Announces Financial Results
- 20 Jul 11 Entry into a Material Definitive Agreement
- 15 Jul 11 Termination of a Material Definitive Agreement
- 16 May 11 Angiotech Pharmaceuticals Announces Final Implementation of
- 29 Apr 11 Angiotech Pharmaceuticals, Inc. Announces Extension of Exchange Offer and Supplement to Offering Memorandum
- 25 Apr 11 Entry into a Material Definitive Agreement
- 11 Apr 11 Other Events
Filing view
External links